Page 24 - The Indian Optician Digital Edition May-Junel 2022
P. 24
AMIKACIN A month after beginning treatment with amikacin, the infection
TO TREAT completely resolved.
“Topical steroids should be cautiously used since they are
INFECTIOUS associated with worse visual outcomes,” reported the authors.
KERATITIS
MENICON LAUNCHES MYOPIA
A team of clinicians from the CONTROL TREATMENT PLAN
US, suggest using amikacin, a
medication used to prevent or
treat a wide variety of bacterial
infections, as a first line therapy
once a diagnosis of Nocardia
keratitis is confirmed.
Describing a case of
infectious keratitis caused by
the pathogen Nocardia sienata,
the clinicians informed that a
25-year-old patient with the
infection presented for treatment
after experiencing two months Japanese contact lens manufacturer Menicon has announced the
of worsening pain in his left eye launch of its new holistic treatment plan for myopia control.
as well as an atypical corneal Menicon Bloom, which was initially introduced in the Netherlands
ring infiltrate. in 2019, will now be available in seven more markets, including the
The report that was published UK, France, Spain, Italy, Austria, Australia and Singapore beginning
in BMJ Case Reports, further this month.
revealed that the patient wore Menicon Bloom features two contact lenses that are CE-approved
soft contact lenses but did for myopia control; an orthokeratology lens, Menicon Bloom Night,
not expose them to water. He and an extended depth of focus soft daily disposable contact lens, the
worked in a warehouse that Menicon Bloom Day.
packaged marijuana products.
He had no history of recent travel. According to the company, the treatment plan will include lens
care solutions, fitting software for eye care professionals (ECPs) and
Upon examination, it was a Menicon Bloom app. “This holistic treatment plan helps slow down
found that the visual acuity in the progression of childhood myopia while providing all the tools for a
the affected left eye was 6/12. successful myopia journey,” states the press release.
Corneal cultures for bacteria,
fungus and acanthamoeba did The Menicon Bloom app has been designed to support
not show any growth. communication between the patient and their practitioner, and to
enable the ECP to monitor the patient’s progress.
The patient was treated
with eye drops containing a The launch coincides with the introduction of a new marketing
combination of steroids and campaign, ‘See their imagination bloom,’ which aims to raise
antibiotics for two weeks but his awareness of childhood myopia and possible treatment options, and
condition continued to worsen. illustrate how the treatment plan can be incorporated into children’s
After three weeks, the organism daily routines.
which grew on atypical agar was The company underlined that the prevalence of myopia in
identified as the Nocardia genus, young people has increased in recent decades to around 30% in
prompting a switch in treatment “industrialised societies” in the West, and to “epidemic levels” of over
to amikacin. 90% in some parts of East Asia.
20 THE INDIAN OPTICIAN MAY-JUNE 2022 CONTACT LENS NEWS
